<DOC>
	<DOCNO>NCT02063763</DOCNO>
	<brief_summary>This study aim analyze therapeutic activity TPO-mimetics Eltrombopag Romiplostim bridge therapy splenectomy adult patient primary immune thrombocytopenia .</brief_summary>
	<brief_title>TPO-mimetics Before Splenectomy Adult Primary Immune Thrombocytopenia Patients .</brief_title>
	<detailed_description>Adult immune primary thrombocytopenia autoimmune malignancy characterize platelet destruction inadequate platelet production . Its incidence three case per 100,000 people year , prevalence woman young old adult . Splenectomy , still today , therapeutic approach offer big guarantee long term response ( around 60+70 % ) . Nevertheless , splenectomy may accompany peri-operative complication almost 10 % patient , rare case may fatal . These normally hemorrhagic complication due low platelet count . Thus , previous therapy increase platelet advisable splenectomy . In patient refractory corticosteroid immunoglobulin use indicate , splenectomy potential risk complication . Since last year , count TPO-mimetic drug , specific c-MPL receptor , able stimulate platelet production , romiplostim eltrombopag . Nowadays , TPO-mimetics allow Italy patient refuse splenectomy splenectomy contraindicate , ITP low platelet count ( &lt; 20-50.000/mmc ) potential contraindication splenectomy due hemorrhagic event , drug consider . Nevertheless , data therapeutic risk safety agent use indication . The aim present study verify , Italian national scale , frequency use , impact safety profile .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>Persistent chronic ITP symtomatic phase . 18 year age old . Indication splenectomy due refractory response previous therapy . Have use eltrombopag romiplostim increase platelet count splenectomy . Have undergone splenectomy . No informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Adult patient</keyword>
	<keyword>Immune primary thrombocytopenia</keyword>
	<keyword>Splenectomy</keyword>
	<keyword>TPO-mimetics</keyword>
	<keyword>Eltrombopag</keyword>
	<keyword>Romiplostim</keyword>
</DOC>